Insider buying
~$12K1,000 sh @ $11.70
Traded Apr 15 · filed 2 days later
A Keros Therapeutics director paid $12K out of pocket for Keros Therapeutics shares. Shares held went up 13% with this purchase.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Feb 24, 2026 · Filed Mar 27, 2026
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
grant award
Code A — grant or award
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Insider buying
Traded Apr 15 · filed 2 days later
A Keros Therapeutics director paid $12K out of pocket for Keros Therapeutics shares. Shares held went up 13% with this purchase.
Insider filing
Traded Apr 2 · filed 4 days later
Derivative exercise or conversion — not an open-market buy.
Insider filing
Traded Apr 2 · filed 4 days later
Derivative exercise or conversion — not an open-market buy.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.